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KESAN PROGRAM PENDIDIKAN BERTERUSAN DIABETES TERHADAP 
PERGAMAL, SIKAP DAN AMALAN PENGAMAL PENJAGAAN 
KESIHATAN DAN KESANNYA TERHADAP HASIL DIABETES 
PESAKITDI BANDAR MUKALLA, YAMAN 
 
ABSTRAK 
 
Diabetes mellitus merupakan salah satu suatu masalah kesihatan awam utama dunia 
yang dikaitkan dengan peningkatan morbiditi, mortaliti (kematian), penggunaan dan 
kos penjagaan kesihatan. Di antara tahun 1986 dan 1990, prevalens diabetes di 
Yaman adalah lebih kurang 4.7%. Dalam tahun 2004, prevalens diabetes jenis II di 
Yaman telah dilaporkan sekitar 4.6% dengan lebih tinggi (7.6%) dikalangan lelaki 
berbanding wanita (2%). Kajian ini dijalankan di bandar Mukalla, Hadramout, 
Yaman untuk menilai kesan program pendidikan berterusan (CE) terhadap 
pengetahuan, sikap dan amalan (KAP) dalam kalangan pengamal penjagaan 
kesihatan (HCPs) di Yaman. Kajian juga menilai sama ada CE, HCPs dapat 
meningkatkan hasil klinikal diabetes pesakit diabetes jenis 2 (kawalan glisemik, 
tekanan darah, berat, profil lipid, serum kreatinin dan urea darah).    
Kajian ini melibatkan dua fasa. Fasa I kajian melihat impak CE diabetes terhadap 
pengetahuan, sikap dan amalan penjagaan diabetes dalam kalangan HCPs. Dalam 
Fasa II, kajian menerokai kesan program CE dalam kalangan HCPs terhadap hasil 
diabetes pesakit. Bagi fasa I, seramai 73 orang HCPs menerima intervensi CE. 
Pengetahuan, sikap dan amalan dinilai menggunakan soal selidik yang telah 
divalidasi. Hasil daripada fasa I menunjukkan bahawa kebanyakkan HCPs 
mempunyai pengetahuan am yang baik tentang diabetes dan pengurusannya sebelum 
mereka menghadiri program CE. Penilaian skor atau markah pengetahuan am dalam 
kalangan HCPs menunjukkan beberapa penambah baikan, walau bagaimanapun 
xxii 
 
peningkatannya tidak signifikan (p=0.31). Keputusan kajian ini mendapati bahawa 
HCPs mempunyai pengetahuan yang baik dalam pemantauan tanda-tanda, gejala dan 
parameter makmal. Penilaian skor pengetahuan terhadap matlamat pengurusan 
diabetes dalam kalangan HCPs mendapati penambah baikan yang signifikan 
(p=0.024) dalam skor pengetahuan. Keputusan laporan kajian ini menunjukkan 
bahawa nilai makmal dianggap sebagai amat penting dalam rawatan pesakit diabetes. 
Kajian juga mendapati bahawa tiada perbezaan yang signifikan dalam skor amalan 
selepas program CE diabetes dalam kalangan HCPs. Di samping itu, kajian ini juga 
mendapati bahawa HCPs mempunyai sikap yang positif terhadap diabetes. Doktor 
mempunyai sikap yang lebih tinggi terhadap diabetes berbanding dengan HCPs lain 
(ahli farmasi dan jururawat) sementara jururawat menunjukkan sikap yang terendah 
dalam kalangan HCPs. 
Bagi fasa II, satu rekabentuk sebelum dan selepas ujian digunakan untuk menilai 
kesan CE oleh HCPs terhadap penjagaan diabetes dan hasil pesakit. Seramai 92 
orang pesakit diabetes jenis 2 menerima penjagaan daripada HCPs yang telah 
menghadiri program CE (Fasa I). Hasil pesakit diukur sebelum dan selepas 1, 3 dan 6 
bulan HCPs menghadiri program CE. Keputusan fasa II menunjukkan bahawa hasil 
pesakit diabetes (paras gula darah, tekanan darah, profil lipid dan fungsi ginjal / 
renal) yang diurus oleh HCPs selepas menghadiri program CE adalah lebih baik 
berbanding sebelum CE. 
Kesimpulannya, program CE dalam diabetes dikalangan HCPs memainkan peranan 
penting dalam peningkatan hasil klinikal pesakit diabetes.  
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THE EFFECT OF DIABETIC CONTINUING EDUCATION PROGRAMME 
ON THE HEALTH CARE PROVIDER’S KNOWLEDGE, ATTITUDE AND 
PRACTICE,AND ON DIABETIC PATIENTS OUTCOMES IN MUKALLA 
CITY,YEMEN 
 
ABSTRACT 
Diabetes mellitus is one of the worldwide major public health concerns which 
associated with increased morbidity, mortality, health care utilization and costs.  
Between 1986 and 1990, the prevalence of diabetes in Yemen was about 4.7%. In 
2004 the prevalence of diabetes type II in Yemen was reported at 4.6% which was 
higher in man (7.4%) compared to female (2%).  This study was conducted in 
Mukalla city, Hadramout, Yemen to assess the impact of continuing education (CE) 
program on Health Care Professionals (HCPs) knowledge, attitude and practice in 
Yemen.  In addition, the study explores whether HCPs CE intervention would 
improve the clinical outcomes of type 2 diabetes patients (glycemic control, blood 
pressure, weight, lipid profiles, serum creatinine and blood urea).  
This study consisted of two phases.  Phase I of the study was looking at the impact of 
diabetes CE on knowledge, attitude and practice of diabetes care among HCPs.  In 
the phase II, the study was exploring the effect of HCPs continuing education 
programme on patient diabetic’s outcome.  In phase I, a total of 73 HCPs received 
continuing education (CE) intervention.  Knowledge attitude and practice (KAP) was 
assessed using a validated questionnaire.  The result from phase I showed that 
majority of the HCPs has a good general knowledge on diabetes and its 
managements prior to the CE program. Evaluation of the general knowledge score of 
the HCPs found some improvement in the knowledge score, however the 
improvement was not significant (p=0.31). The result of this study found that HCPs 
has good knowledge on monitoring the sign, symptoms and laboratory parameters. 
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Evaluation of the knowledge score on Goal of Diabetes Management of HCPs found 
significant (p=0.024) improvement in the knowledge score. The results indicated that 
the lab values were rated as the most important in the goal for the treatment of 
diabetes patients.  The study also found no significant difference in practice score 
after CE program among HCPs.  In addition, this study also found that the HCPs 
have positive attitudes toward diabetes. Doctors have higher attitudes toward 
diabetes   than others HCPs groups (pharmacist and nurses), where nurses   showed 
lowest attitude among HCPs groups.   
For phase II, one pre/post test design was used to evaluate the impact of HCPs CE on 
patient outcomes.  A total of 92 patients with type 2 diabetes patient received care 
from HCPs who have attended the CE in Phase I.  The patient outcomes were 
measured before the HCPs received CE and at 1, 3 and 6 months after the HCPs 
received CE. The result of phase II indicated that diabetic patient’s clinical outcomes 
(blood sugar levels, blood pressure, lipid profile and renal functions) were better 
following managements by HCPs after they have completed a CE programme 
compared to baseline.  
In conclusion, health care professionals’ continuing education (CE) program in 
diabetes and its management plays an important role in the improvement of   patient 
clinical outcomes.  
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CHAPTER ONE: INTRODUCTION 
 
1.1 Background  
 
Diabetes mellitus is a major public health concern and a condition that leads to 
increased morbidity, mortality, health care utilization and costs (American Diabetes 
Association, 2010;  Norris  et al., 2002). Complications related to diabetes have been 
documented, ranging from acute complications such as hypo/hyperglycaemia to 
chronic and serious complications such as those related to micro and macrovascular 
complications.  These chronic and serious complications include heart attacks, 
blindness, kidney failure, stroke and others (DCCT,1993; Keller et al., 1993; 
Campbell et al., 1995; Ohkubo et al., 1995; Uusitupa et al., 1996; Renders et al., 
2001; Umpierrez et al., 2002; Bate &Jerums, 2003; Gaede et al., 2003; Niaz et al., 
2005; Sperl-Hillen & O'Connor, 2005;). 
The diabetic epidemic is a global problem and is not limited to the developed 
countries.  It has been estimated that there are about 366 million diabetic patients 
worldwide and the majority of them are sufferring from diabetes type 2 (Whiting et 
al., 2011). It has been postulated that the number of diabetic patients worldwide in 
the year 2030 could increase to 552 million. 
Yemen is currently undergoing rapid development and is not excluded from the rapid 
increase in the incidences of diabetes (Gunaid &Assabri, 2008).  Between 1986 and 
1990, the prevalence of diabetes in Yemen was about  4.7% ( Gunaid et al., 1997).  
In the year 2000, the prevalence of diabetes in the whole of Yemen had increased to 
6.57% (Gunid, 2002).  Furthermore, in the year 2004, the total prevalence of type II 
diabetes mellitus in the urban cities of Yemen was about 4.6% (7.4% of males and 
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2% of females).  Moreover, the prevalence of impaired glucose tolerance (IGT) and 
impaired fasting glucose (IFG) were found to be 2% and 2.2%, respectively (Al 
Habori et al., 2004).  In 2008, Gunaid and Assabri (2008) reported that the incidence 
of diabetes in Yemen has increased to 10.4%. 
All health care professionals, including neurologists, pharmacists, nutritionists, 
health educators, nurses and other specialists, play significant roles in diabetes 
management (Wagner et al., 2001).  The improvement noted in patient knowledge on 
diabetes and its management has been shown to depend on the instructions received 
from health care professionals (Drass et al., 1989).  Several studies have reported that 
the effectiveness of diabetes education would be optimised if the health care 
professionals have a good knowledge of diabetes and good communications skills 
(Franz et al., 2003; Knowler  et al., 2003; Trento et al., 2003; Balcou et al., 2008). 
Unfortunately, some studies have reported that health care professionals 
(pharmacists, nurses and physicians) have insufficient knowledge and limited skills, 
which hamper in recognising the disease process (Uding et al., 2002; Chen et al., 
2004). Therefore, a continuing education (CE) program and a certificated diabetic 
educator (CDE) program should be created to assist health care providers in updating 
their knowledge and skills in diabetes care. 
Study carried out by Chen et al., (2004) have evaluated that the knowledge of 
pharmacists on diabetes and they found that improvement in the pharmacists’ 
knowledge was very small, from 50% at baseline to 57.2% after the intervention 
program.  Chen et al., (2004) concluded that the pharmacists’ knowledge was still 
inadequate and suggested that pharmacists should undergo additional training on 
diabetes and its management to improve their competency. 
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Studies have also reported that nurses' knowledge on diabetes is also inadequate. 
Three of these studies assessed the nurses’ knowledge using the DKT. These studies 
found that the nurses’ level of knolwedge was between 66 % and 77 % of the total 
correct answer (Moriarty & Stephens, 1990; El-Deirawi & Zuraikat, 2001; Drass et 
al., 1998).  Therefore, Drass et al. (1998) suggested that additional diabetes education 
programs are needed for all professional nurses to increase their knowledge and 
skills in diabetes. 
According to O'Brien et al., (2009), in 32 studies it was suggested that continuing 
education programmes and workshops could improve health care professionals’ 
practices. An education intervention programme for health care professionals plays 
an important role in the management of diseases, patients and their lives as well as 
their health problems. Health care professionals’ education programme has been 
shown to improve the quality of care of diabetes patients and yield the best results in 
clinical outcomes (Lewin et al.,2001; Van Zyl and Rheeder et al.,2004; Thom et al., 
2006; Chehade et al., 2010; Sequist et al., 2010; Speril-Hillen et al., 2010).   
Studies have also shown that health care professionals’ education with or without  
diabetes patients education could prevent or delay complications of diabetes (Deeb 
et.al.,1988).  Several studies have reported that improved glycemic control, reduction 
in cholesterol and the control of blood pressure (BP) could reduce complications and 
improve outcomes (Klein et al., 1984; Nathan et al., 1986; Ohkubo et. al., 1995; 
DCCT 1993; Campbell et al., 1995; Uusitupa et al., 1996; Renders et al., 2001; 
Gaede et al., 2003; Sperl-Hillen & O'Connor, 2005). 
In this study, we attempt to describe and assess the effect of HCPs professionals’ CE 
programme on the clinical outcomes in type 2 diabetes patients.  The HCPs that 
4 
 
attended the CE in Section One of the research were involved directly in the 
management of patients in Diabetic Clinic, Mukkala City. The patients’ outcome 
parameters were monitored before and after the intervention given by the HCPs after 
the CE programme. This makes it possible to assess the effect of the CE to the 
patient diabetes outcome.  
1.2   Problem statements  
Diabetes is one of the commonest and costly chronic diseases, with 366 million 
people currently diagnosed globally (Whiting et al., 2011).   Developing countries 
are  projected to experience a tremendous increase in the number of diabetic cases, 
from 84 million to 228 million by 2025. Therefore, by the year 2026, over 75% of all 
the people with diabetes are expected to be in the developing countries, compared to 
62% in 1995(King et al., 1998).  By the year 2030, approximately 388 million 
diabetic patients are expected worldwide (CDC, 2005).  The increase in the 
prevalence of diabetes in the develop countries such as Middle East and North Africa 
due to obesity rate (Hossan et al., 2007).  
According to the (Sicree et al., 2010), six countries in the Middle East were rated in 
the top 10 countries in the word with the highest prevalence of diabetes.  These 6 
countries were the United Arab Emirates, which has the second highest diabetes rate 
in the world, followed by Bahrain, Egypt, Kuwait, Oman and the Kingdom of Saudi 
Arabia.  As for Yemen, being one of the countries currently undergoing rapid 
development, it is faced with the challenge of an increasing number of diabetic 
patients (Wild et al., 2004). (Al-Habori et al., 2004)  reported that the total 
prevalence of type II DM was recorded at about 4.6% (7.4% in males and 2% in 
females). 
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The increase in the prevalence of diabetes globally needs some kind of intervention 
that could be useful in retarding the progression of this disease.  One of the steps that 
has been shown to be useful is improving the level of knowledge on the disease and 
its management among health care providers and patients (Fedderson & Lockwood, 
1994; Amos et al., 1997; Moghissi & Hirsch, 2005; Haas, 2006).  For health care 
providers, a systematic and recognised program such as the certified diabetes 
educator (CDE) program is very important to ensure that the information provided by 
health care providers is consistent. If the diabetes education effort is effective, the 
severity of the condition could be seriously lowered (Schwedes et al., 2002). 
According to Plake et al. (2003), pharmacists’ knowledge on diabetes is still poor; 
therefore, they need additional training regarding diabetes diagnosis and its 
management. The diabetes attitudes scale (DAS) is a well-validated instrument, 
which has been widely used to successfully measure attitudes of physicians and 
nurses, but there is a little information on pharmacists’ attitudes (Chen et al., 2004). 
Numerous studies have shown a lack of knowledge on diabetes among nurses.  Many 
researchers, who conducted repetitive studies utilizing the diabetes basic knowledge 
test (DBKT), found that nurses still had inadequate knowledge on diabetes care 
(Drass et al., 1989; El-Deirawi & Zuraikat, 2001; Wright, 2008).   Therefore, there is 
a need to improve nurses’ knowledge on diabetes care, since nurses are the largest 
group of health care professionals who spend the longest time with diabetic patients. 
Additionally, there is very little data on the level of knowledge and awareness on 
diabetes in developing countries such as Yemen. Such data is extremely important in 
the planning of public health policies, with specific reference to its national 
implementation. Studies have shown that the prevalence of diabetes in Yemen is 
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increasing, while education about diabetes is still not established (Al-Habori et al., 
2004; Almikhlafy et al., 2008). In most countries, health care providers adopt a 
standard guideline for diagnosing and managing diabetic patients; however, the 
existence of such guidelines is still not widely available in Yemen. Therefore, the 
information on the level of knowledge, attitude and practice of health care providers 
on diabetes and its management is useful for policy makers in Yemen to develop a 
model that could be adopted by the practitioners in the whole country. 
Health care professionals’ education programmes are essential for improvements in 
glycemic control, blood pressure, weight loss and lipid levels.  At the present time, 
no studies have been found, which evaluate whether health care professional 
education interventions have any effect on clinical outcomes in T2DM in Yemen.  
Therefore, this present study aims to answer the following question: what effect 
would a health care professional’s diabetes education programme have on clinical 
outcomes including fasting blood glucose, blood pressure, weight, renal and lipid 
profiles of type 2 diabetes patients? 
1.3 The rationale of study   
Diabetes is a chronic disease, which affects the lives of millions of people all over 
the world. Studies have shown that education interventions are designed to improve 
glycemic control, patient knowledge, self-care behaviours, and blood pressure 
control, as well as to reduce lipid levels and prevent or delay   diabetes complications 
(Susan et al., 2002; Ismail et al., 2005; Madonna, 2008). 
Many studies reported that the health care professionals’ diabetes education 
programmes improve glycemic control by reducing HbA1C and fasting blood sugar, 
controlling blood pressure and reducing cholesterol. They could also reduce 
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complications of the progress of the disease (Klein et al.. 1984; Nathan et al., 1986; 
DCCT, 1993; Ohkubo et al., 1995; Campbell et al., 1996; Uusitupa et al., 1996;  
Norris et al., 2001; Renders et al., 2001; Gaede et al., 2003; Parchman et al., 2003; 
Steed et al., 2003; Sperl-Hillen & O'Connor, 2005).  Presently, there are no studies 
on whether the care providers’ education interventions have any effects on blood 
glucose level and metabolic risk factor in T2DM in Yemen. 
1.4  Significance of the study 
This study explored the level of knowledge, attitude and practice in diabetes care 
among health care providers in Mukalla, Yemen.  The study also looked at the 
outcome of diabetes treatment before and after the intervention (in the form of 
diabetes education) by health care providers. 
This study will provide the basic information on the level of knowledge, attitude and 
practice in diabetes care among doctors, pharmacists and nurses.  This information 
could be used to assist the relevant authority in designing specific educational 
programs to enhance the level of knowledge and skills of health care providers in 
diabetes and its management.   
 The finding of the study could also be relevant for health care societies such as the 
Pharmaceutical Association, Medical Association and Nursing Association.  They 
could use the information obtained from this study to design specific programs or 
educational programs tailored for their profession’s need to improve diabetes care.   
The results of the present intervention could provide evidence for improving 
glycemic control in the population studied. This could be used to aid health care 
providers and programme directors in the design and the delivery of standardised and 
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effective care in the area of diabetes control and management. 
This study could also assist physicians and nursing practitioners by increasing their 
professional knowledge regarding the effectiveness of education intervention on 
blood glucose level, blood pressure, weight and renal assessment of patients with 
type 2 diabetes. If this type of intervention has effect on clinical outcomes of the 
patient with T2DM, then the strategy could be adopted by the health care 
professionals to assist their patients. 
1.5 Hypotheses of the study 
Hypothesis 1: The current level of knowledge and attitude among health care 
professionals is still inadequate. 
Hypothesis 2: There will be a significant effect of education intervention (i.e., 
presentation) on the knowledge of health care professionals. 
Hypothesis 3: There will be significant differences between health care professionals 
(pharmacists, doctors and nurses) for the knowledge diabetes scores. 
Hypothesis 4: There will be a significant effect of our education intervention (i.e., 
presentation) on the perception of health care professional. 
Hypothesis 5:  There will be significant differences between health care professionals 
(pharmacists, doctors and nurses) on practice scores. 
Hypothesis 6: There will be a significant effect of education intervention (i.e., 
presentation) on the attitude of health care professionals. 
Hypothesis 7: There will be significant differences among the health care 
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professionals (pharmacists, doctors and nurses) toward diabetes attitudes subscales. 
Hypothesis 8: There will be effect of health care professionals’ intervention on 
clinical outcomes; fasting blood sugar, blood pressure, weigh, lipid profiles (i.e. total 
cholesterol, LDL cholesterol, HDL cholesterol and TG ) and renal profiles(i.e. serum 
blood urea and serum creatinine) at baseline, before the intervention programme, at 
one month  after and at six months after the intervention. 
1.6 Study objectives 
1.6.1 Main objective 
At present, there is no available data on the level of knowledge, attitude and practice 
(KAP) in diabetes care in Mukalla city, Yemen.  In view of this, the main objective 
of this study was to assess the current level of KAP in diabetes care among health 
care providers, namely doctors, pharmacists and nurses in Mukalla city, Yemen.  In 
addition, the study also evaluated the improvement in a KAP intervention program in 
diabetes care among health care professionals in Mukalla city. 
In addition, this study was to evaluate the effect of health care professionals’ 
intervention on clinical outcomes in type 2 diabetes patients in Mukalla City, Yemen. 
1.6.2 Specific objectives 
1. To assess the level of health care professional’s knowledge on symptoms, 
treatment, complications and life style modifications. 
2.  To evaluate the attitude of health care providers with regards to training of 
diabetes, complications and the monitoring of blood glucose.  
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3. To determine the practice of health care professionals in the diagnosis, 
investigation and treatment of diabetes.  
4. To assess the improvement of health care provider s’ KAP after a CE programme. 
5.  To determine the effects of health care professionals’ intervention on clinical 
outcomes in type 2 diabetes patients at baseline, before the intervention programme, 
at one month, three and  six months after the intervention. 
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CHAPTER TWO:  LITERATURE REVIEW 
 
2.1   Introduction 
This chapter provides a review of the literature related to the knowledge, attitude and 
practice in diabetes care among health care providers.  To facilitate the discussion, 
the chapter is divided into nine major sections.  The first section provides a 
background review of Yemen, the second provides the diabetes in Yemen, and the 
third gives the diabetes risk factor in Yemen.The fourth give global prevalence of 
diabetes. The fifth gives the general diabetes information.  The sixth provides the 
knowledge, in diabetes care among health care providers; the seventh provides a 
review of attitude in diabetes care among health care providers, while the eighth 
section gives a review of practice in diabetes care among health care providers.  The 
ninth section provides diabetes education programs and its effect on KAP among 
health care professionals. The tenth section reviews the effectiveness of health care 
professionals’intervention on patientsoutcomes.   
2.2 The health care system and education in the republic of Yemen 
Prior to 1990, the Republic of Yemen (ROY) was divided into two: North Yemen, 
which was known as the Yemen Arab Republic (YAR), and South Yemen, which 
was the People´s Democratic Republic of Yemen (PDRY).  In May 1990, both South 
and North Yemen was amalgamated and became the Republic of Yemen.  With the 
unification, all the management of government was carried out from the capital of 
Yemen, Sana’a. Sana’a also governs the health care system, which includes facilities, 
policy, and manpower as well as drugs supply.  There is no recent data on the health 
care facilities in Yemen; however, the latest data available was for the year 2004.  
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There were 42 government hospitals (93  private ), 470 polyclinics (341 private), 626  
health centers (115 private), 2,185  primary health care units, 380  maternity and 
child health centers, 1,768 private pharmacies, and  4,799 physicians (329 dentists 
and 974 specialists)  to provide services to 22.2 million inhabitants.  In 2007, a report 
from the U.S. government and United Nations showed that the population of Yemen 
was composed of 46 % under 15 years old, while 51 % of the population was 
between 15 and 64 years old and less than 3 % was 65 and older.  The data also 
showed that the universities offering medical, pharmaceutical, dental, nursing and 
other health-related programs were limited.  In the year 2011, the total number of 
universities offering health-related programs in Yemen was only 5, namely Sana’a 
University, Aden University, Hadramout University, Thomar University and one 
private institution, the Science and Technology University.  The limited number of 
educational institutions offering health care-related programs was unable to provide 
an adequate supply of manpower to meet the health care providers to patient ratio set 
by WHO. 
2.3  Diabetes in Yemen 
2.3.1  Diabetes prevalence and its complications in Yemen  
The knowledge of diabetes epidemiology among Yemenis is yet to be properly 
established (Almikhlafy et al., 2008). A recent cross sectional study carried out by 
Almikhlafy et al., (2008), aimed to determine the prevalence of diabetes mellitus 
among Yemeni physicians in Sana’a city Yemen,  and  to find the relationship 
between gat chewing and diabetes mellitus. The sample size of this study was 332 
physicians. Data was collected by a questionnaire consisting of basic demographic, 
socio-economic, medical and drug history. However, the questionnaire did not 
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mention where the pilot study was done, which may contribute to the validity of the 
findings. In addition, fasting blood samples were taken to measure glucose levels.  
The prevalence of diabetes among Yemeni physicians was about 10% and there was 
no relationship between gat chewing and diabetes mellitus. However, the study does 
not represent the typical problems in Yemen as the sample size was small and it was 
carried out only in three government hospitals in Sana’a city. A earlier  study was 
conducted in the capital city, Sana'a, among 1080 Yemeni people by Guniad et al., 
(1997). The author found the crude prevalence of known diabetes to be 6.57%, while 
the age-standardized prevalence for the age ranging between 30–64 years was 9.75%. 
In addition, it was discovered that history of diabetes was found in 33.7% of IDDM 
patients: 30% for non-obese NIDDM patients, 39.2% for obese NIDDM patients and 
33% for the whole number of subjects studied.     
Al-Habori et al. (2004) carried out a cross sectional study in Sana’a city, Yemen 
among 498 adults with ages ranging from 25–65 years.  They examined the 
prevalence of diabetes mellitus and impaired glucose tolerance (IGT), as well as 
identified the metabolic abnormalities and risk factors associated with these 
conditions. All residents who were ≥25 years were screened for type II Diabetes 
Mellitus and impaired glucose tolerance (IGT) as well as impaired fasting glucose 
(IFG).  The result of the study revealed that the prevalence of diabetes was 4.6 %, 
impaired glucose tolerance (IGT) was 2% and impaired fasting glucose (IFG) 
represented 2.2%. In addition, the authors found that 80% of the type II diabetics 
were over 40 years old, 35% had hyperlipidemia, 22% were hypertensive and 18% 
were obese, whereas 60% of IGT subjects had hyperlipidemia and 20% were obese. 
One of the problems of this study was the small sample size, which may increase 
Type II error.  Another study was carried out among 1080 adults by Gunaid in 
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Sana’a city (Gunaid, 2002).  Gunaid found that the demographics of Yeminis were 
similar to those reported by Al-Habori etal,(2004) where the majority of Yemeni 
people above 25 years have higher risk of developing diabetes. However, Gunaid’s 
study found that the crude prevalence of known diabetes was 6.57%. Both studies 
established that diabetes mellitus was more prevalent in males than in females.     
Another recent study carried out in Sana’a city by Gunid and Assarbi (2008) aimed 
to explore the prevalence of diabetes mellitus and abnormal glucose tolerance as well 
as other cardiovascular risk factors. The sample of this study was 250 adults aged ≥ 
35 years in a semirural area near Sana’a, the capital of Yemen. Medical history and 
clinical data collected included BP, weight and BMI. Whole blood glucose 
concentration and 2 hours after oral glucose load were taken to screen diabetes 
mellitus and abnormal glucose tolerance as well as other cardiovascular risk factors. 
The findings of this study were that the crude prevalence of diabetes type 2 was 
10.4%, while the age-standardized prevalence for those aged over 35 years was 
6.3%. Moreover, the age-standardized rate of either impaired fasting glucose or 
impaired glucose tolerance was 9.0%, and the age-standardized prevalence of 
hypertension was 14.2% (Gunaid and Assabri, 2008). 
Al-Khawlani et al. (2010) conducted another study in Sana’a, among 311 type 2 
diabetes patients above 25 years old. The authors explored the prevalence of 
macrovascular complications and their association with glycemic control, as well as 
other risk factors in patients with type 2 diabetes mellitus. Physicians collected the 
data related to history, BP, BMI, symptom of peripheral vascular diseases (PVD), 
coronary heart diseases (CHD) and history of cardiovascular diseases (CVD). FBG 
was determined using WHO standard protocols (WHO, 1999). They found that 
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53.4% of subjects had hypertension, 34.1% were overweight, 8.7% were obese and 
87.9% had poor glycemic control (HbA1c ≥ 7%). In addition, it was reported that 
25.4% of diabetes patients with type 2 had symptoms of macrovascular 
complications, PVD (9.1%), CHD (17.8%) and CVD (5.8%). This study showed that 
risk factors for CHD were age and, hypertension, while risk factors for PVD were 
male sex, age, duration of diabetes and smoking. 
Studies have reported that diabetes and its complications are the major public health 
concern in Yemen. Data in 2004 demonstrated that the prevalence of diabetes 
retinopathy among diabetic patients in Yemen was 55% (Bamashmus et al., 2009).  
Hypertension is another common illness associated with diabetic patients in Yemen, 
where 55% of patients have hypertension.  The prevalence of retinopathy and 
neuropathy complications among Yemeni diabetic patients with hypertension have 
been reported to be 38.5 % and 54.3 %, respectively.  In addition to that, the 
prevalence of peripheral neuropathy has been reported to be about 89.4%. For 
macrovascular complications, ischemic heart disease is the most common at 28.8% 
followed by peripheral vascular disease (13.5 %) and stroke (8.7%).  On the other 
hand, in diabetic patients without hypertension, the prevalence of complications are 
slightly lower.  The prevalence of retinopathy in non-hypertensive diabetic patients is 
20.4%, neuropathy 32.8 % and peripheral neuropathy 74.1 %.   A similar trend were 
observed in the macrovascular complications of non-hypertensive diabetic patients 
where ischemic heart disease is 12.9 %, peripheral vascular disease 10.6 % and stoke 
5.9 % (Al-Khawlani et al., 2009).  Another recent study in the city of Sana’a, Yemen, 
by Al-Khawlani et al. (2010) found that the prevalence of coronary heart disease was 
17.8%, peripheral vascular disease 9.1% and cerebrovascular disease 5.8%.  This 
sudden drop in the prevalence of diabetes-related complications may represent the 
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variations in the population of the study. 
2.3.2   Diabetes Risk Factor in Yemen 
There are several factors have been identified as the risk factors for diabetes. There 
are three studies conducted in Yemen to explore the specific risk factors contributed 
to the recent increase in diabetes incidents.  A study by Al-Habori et al. (2004) 
reported a high incidence of diabetes in Sana’a city. The study was conducted among 
498 adults (≥25 years of age) and found that 80% of the type II diabetics have an age 
above 40 years old. The prevalence of obesity (BMI≥30 kg/m2) was higher among 
the normal glucose tolerant (78%), and 35% were hyperlipidemia. Study by Guniad 
and Assabri (2008) found that being over 55 years old and having a waist 
circumference ≥ 102 cm for men and ≥ 88 cm for women have higher risk to  total 
glucose intolerance (TGI). In addition, the family history was also identified as a risk 
factor for diabetes mellitus. A more recent study in Sana’a city by Almikhlafy et al. 
(2008) found that age, physical inactivity and smoking significantly increased the 
risk factor of diabetes among Yemeni physicians. 
2.4 Global prevalence of diabetes 
Globally, the estimated prevalence of diabetes in the year 2000 was between 147 and 
154 million people (King et al., 1998).  In 2001, the prevalence of diabetics 
worldwide was estimated at about 150 million and this is expected to increase to 220 
million by 2010 and to 300 million by 2025 ( King et al., 1998; Zimmet et al., 2001).  
Developing countries are expected to experience an increase in the number of 
diabetes from 84 million to 228 million in the same time frame. Based on the above 
estimation, 75% of all the total number of diabetes in 2006 was expected to come 
from the developing countries, compared to 62% in 1995 (King et al., 1998). 
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According to the IDF (2009), it was reported that six countries in the Middle East 
were rated in the top 10 countries in the world with the highest diabetes prevalence.  
The 6 countries included the United Arab Emirates, which has the second highest 
diabetes rate in the world, followed by Bahrain, Egypt, Kuwait, Oman and the 
Kingdom of Saudi Arabia.  Yemen, being one of the countries currently undergoing 
rapid development, is faced with the challenges of increasing number of diabetic 
patients. Al-Habori et al. (2004) reported that the total prevalence of T2D was 
estimated at about 4.6% (7.4% in males and 2% in females).   
Several studies have reported on the prevalence of diabetes in some countries of the 
Middle East, including: the Kingdom of Bahrain, 25.5% (Farouq  et al.,1996); 
Kingdom of Saudi Arabia, 23.7% (Mohieldein et al., 2011; Al-Norzha et al., 2004); 
Lebanon, 21%; Kuwait, 14.8% (Abdella et al, 1998); Jordan, 13.4% (Ajlouni et al., 
1998); Egypt, 13.1% (Herman et al., 1995); Oman, 7 to 13% (Al-Lawati et al., 2002).  
With these percentages, the expected number of diabetes in the Middle East alone 
could contribute to a significant percentage of the total global number of diabetic 
patients. 
2.5  General diabetes information  
2.5.1 Etiology and classification  
Diabetes is classified based on its etiology, namely diabetes type I (T1D), diabetes 
type II (T2D), gestational diabetes (GDM) and other specific types of diabetes (e.g. 
genetic defects in insulin action, diseases of the exocrine pancreas (cystic fibrosis), 
and drug- or chemical-induced e.g.in the treatment of HIV/AIDS or after organ 
transplantation. Other specific types of diabetes, e.g. genetic defects in β-cell 
function; several types are due to monogenetic defect in β-cell function. These types 
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of diabetes are developed at an early age and characterized by sudden onset of 
hyperglycaemia. Genetic defects in β-cell function are referred to as maturity onset 
diabetes of the young (MODY) (ADA, 2010). Type I diabetes (T1D) is more 
common in children and adolescents. The main cause is linked to the autoimmune-
mediated destruction of pancreatic B-cells, resulting in the reduction or absence of 
insulin secretion. T1D accounts for about 10% of all diabetic patients and requires 
daily injections of insulin. T1D patients are more prone to develope ketoacidosis and 
other symptoms such as polydipsia, excess urination, fatigue, blurred vision and 
rapid weight loss (CDC, 2005; ADA, 2010). 
T2D is also known as non-insulin dependent diabetes mellitus (NIDDM) and occurs 
predominantly in adults above forty years old who are obese and have a family 
history of diabetes. T2D accounts for approximately 90% of diabetic cases (ADA, 
2008). There are various risk factors associated with T2D and most patients have 
several of these risk factors prior to the onset of diabetes. These risk factors include 
pregnancy, obesity, hypertension, inactive lifestyles and family history (CDC, 2005). 
Treatment of T2D generally includes dietary modifications, weight reduction, 
physical activity and a combination of several oral medications (CDC, 2005; ADA, 
2008). 
Gestational diabetes mellitus (GDM), on the other hand, occurs only during 
pregnancy. Obesity and a family history of diabetes are common factors contributing 
to the development of gestational diabetes (CDC, 2005).  Other risk factors for GDM 
are raised fasting blood glucose or random blood glucose levels and glycosuria 
(Hanna & Peters, 2002).  Women diagnosed with gestational diabetes are more likely 
(5% to 10 %) to develop T2D (CDC, 2005). Those who are at risk of gestational 
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diabetes should be tested as soon as possible.  If gestational diabetes is not found at 
initial screening, the women should be retested after 24 weeks of gestation (ADA, 
2008). Gestational diabetes must be treated during pregnancy to avoid complications 
to the infant.   
Treatment of gestational diabetes generally includes close blood glucose monitoring, 
which can be done by physicians, nurses or the patient herself. Women with GDM 
should be encouraged to participate in physical activity and dietary modification.  
Finally, insulin can be recommended when diet and exercises fail to maintain fasting 
blood glucose level ≤150mg/dl (5.8 mmol/l) (Chan et al.,2004). 
2.5.2 Diabetes complications 
Diabetes is a serious public health disease leading to high morbidity and mortality.  It 
is associated with various serious complications and could lead to death if not 
properly treated.  According to the CDC (2007), most of the complications from 
diabetes are associated with the poor control of T2D.  The major goals of diabetes 
management are therefore to achieve euglycaemia and prevent the development of 
complications.  There are two types of complications in diabetes: acute and chronic. 
The acute complications of diabetes are hypoglycaemia, diabetic ketoacidosis (DKA) 
and hyperglycaemia.  Diabetic ketoacidosis (DKA) is more common in T1D, while 
hyperglycaemia occurs in type 2 diabetes.  On the other hand, chronic complications 
(long-term complications) are not directly related to blood sugar level, but are linked 
to changes in the histopathology of macro and microvasculature. The prevalence of 
microvascular and macrovascular complicationsare usually associated with the 
duration of diabetes and blood sugar control.  Microvascular complications are more 
common in T1D, while macrovascular complications are more prevalent in T2D, 
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which contributes to the main cause of morbidity and mortality in T2D. The presence 
of microvascular complications such as retinopathy, nephropathy and others may run 
undetected even before the diagnosis is made (Bate & Jerums, 2003).  Several studies 
have documented that a good control of blood sugar, reduction in cholesterol and 
blood pressure control could reduce complications and improve outcomes in both 
types of diabetes (DCCT, 1993; Ohkubo et al., 1995; Campbell et al., 1995; Uusitupa 
et al., 1996; Renders et al., 2001; Bate & Jerums, 2003; Gaede et al., 2003; Sperl-
Hillen & O'Connor, 2005). 
2.5.2.1 Acute complications   
This mainly occurs in T1D, which often affects young diabetic patients.  The clinical 
manifestations of diabetic ketoacidosis (DKA) are related to insulin deficiency with 
hyperglycaemia (blood glucose level ≥ 200 mg/dL), lipolysis, increased production 
of ketone bodies and acidosis (pH≤ 7.3). Some other participating factors found to 
worsen DKA include infections, hypercatabolism secondary to acute illness, 
inadequate diabetes knowledge, non-compliance to therapy and inadequate glucose 
monitoring (Keller et al., 1993; Umpierrez et al., 2004; Niaz et al., 2005;).  
Prevention of DKA is very important and could be done by improving patient 
adherence to diabetes education, adequate self-care and compliance to insulin and 
self-monitoring of blood glucose level. In general, the treatment of DKA involves 
adequate hydration therapy, insulin infusion therapy and electrolyte replacements. 
Hyperosmolar hyperglycaemic syndrome (HHS) is clinically characterised by an 
elevated blood glucose (> 600 mg/dL), elevated serum osmolality (>320 mOsm/kg) 
and the absence of ketoacidosis (Kitabchi & Fisher, 2008). HSS usually occurs in 
elderly patients who refuse to drink adequate amount of fluid and hence, leads to 
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severe dehydration.  Treatment of HHS should be initiated by reversing the 
dehydration with large volume fluid replacement, close monitoring of blood glucose 
level and insulin therapy may sometimes be needed (Umpierrez et al., 2004) 
2.5.2.2    Long-term complications 
The long-term complications of diabetes are usually associated with the prolonged 
fluctuation in blood glucose level, as well as changes in the lipid profile.  Chronic 
complications can be divided into two types, namely macro and microvascular 
diseases. Macrovascular diseases refer to heart and peripheral vascular diseases, as 
well as cerebrovascular diseases (Wilson et al, 1998; Laing et al, 2001; Paterson et 
al, 2007). Microvascular diseases include blindness (retinopathy), kidney disease 
(nephropathy), nerve damage (neuropathy) and infections that lead to gangrene and 
amputation (Ohkubo et al, 1995; Feire et al., 2002 ) 
Macrovascular complications of diabetes include coronary heart disease (CHD), 
stroke and peripheral arterial diseases (Avogaro et al., 2007).  Coronary heart 
diseases and stroke are the major complications leading to morbidity and mortality in 
diabetes (Stamler et al., 1993; Wilson, 1998; Beckman et al., 2002; Beckman et al., 
2007; Buse et al., 2007). In addition, myocardial ischemia arises from coronary 
atherosclerosis and is also common in diabetes (Wingard et al., 1993). Subsequently, 
myocardial infarctions could also lead to heart failure (Haffner et al., 1998; Paterson 
et al., 2007).  Moreover, cerebrovascular disease is more commonly found in T1D 
(Laing et al., 2003).   
Studies have shown that intensive glycemic control in type I diabetes through the 
lowering of HbA1C is associated with a reduction in all cardiovascular diseases and 
a decrease in myocardial infarction and stroke ( Nathan et al., 2005; Paterson et al., 
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2007).  By contrast, intensive blood glucose control in type 2 diabetes does not 
improve macrovascular complications, but it has been reported that the control of 
hypertension in T2D improves macrovascular complications (UKPDS, 1998; Turner 
et al.,1998).  Studies have reported that the control of blood pressure in diabetic 
patients could be achieved with ACE inhibitors or angiotensin receptor blockers 
(ARBs) (Beckman et al., 2002; Lindholm et al., 2002). Moreover, there is an 
additional benefit in the use of ACE inhibitors and ARBs in diabetic patients because 
both are useful for arresting the progression of diabetic microvascular kidney 
disease. 
Another approach in the prevention of macrovascular complication of diabetes is by 
controlling lipid concentrations.  Several studies have reported a reduction in 
triglycerides and LDL cholesterol concentrations and increased HDL cholesterol 
using lipid lowering agents, particularly statins, which are very useful in reducing 
these complications (Beckman et al., 2002; Colhoun et al., 2004; Buse et al., 2007). 
Retinopathy, nephropathy and neuropathy are the main presentations of 
microvascular complications in diabetes.  Diabetic retinopathy is one of the major 
microvascular complications of diabetes and is more common in type I diabetes 
(Keenan et al, 2007). It occurs early, within 7 years before the diagnosis of type 2 
diabetes (Fong et al, 2003). According to a study carried out by Bamashmus et al. 
(2009) in Sana’a, Yemen, among diabetes patients, the prevalence of diabetic 
retinopathy was 55%, blindness 16% and cataract and glaucoma 34.3% and 8.6%, 
respectively. Some recommendations to reduce the progression of diabetes 
retinopathy include tight glycemic control, control of blood pressure and regular 
dilated eye examination at least annually (ADA, 2008). 
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Diabetic nephropathy is indicated by the presence of proteinuria above 500 mg in 24 
hours or the presence of microalbuminuria in the urine (target albumin excretion of 
30 to 299 mg/24 hours).  Diabetes nephropathy has been implicated as the major 
cause of renal failure and represents the majority of dialysis patients in the world.  
Treatment is based on the prevention of progression.  Like the other microvascular 
complications, it can be prevented or reduced by tight glycemic control (DCCT, 
1993; Adler et al., 2003; Gross et al., 2005). Studies have demonstrated that 
treatment with angiotensin-converting enzyme (ACE) inhibitors and angiotensin 
receptor blockers (ARBs) reduces the risk of diabetic nephropathy (Gross et al., 
2005).  A good control of blood pressure in diabetes patients reduces the progression 
of microalbuminuria, especially with the use of ACE and ARBs (Gross et al., 2005; 
ADA, 2008). 
Diabetic neuropathy is defined as a loss of pain sensation in the lower extremities 
and subsequently, can lead to peripheral nerve dysfunction, increased infection and 
joint dysfunction (ADA, 2007).  Peripheral neuropathy in diabetes has many forms, 
such as sensory, multifocal and autonomic neuropathies.  Amputation usually arises 
after foot ulceration, which refers to diabetic neuropathy (Boulton et a.l, 2005). 
Neurological dysfunction refers to diabetic autonomic neuropathy and its clinical 
manifestations are gastroparesis, constipation, diarrhoea, bladder dysfunction, 
erectile dysfunction, tachycardia, silent ischemia and sudden cardiac death (Boulton 
et al., 2005; ADA, 2007).  The primary goal of treatment is  to relieve the symptoms  
and prevent  the progression of neuropathy, which could be achieved  by controlling 
the blood glucose level.  Diabetic patients should be educated more regarding 
diabetes self-care (ADA, 2007).  To date, there is no specific medication for treating 
diabetic neuropathy, but some drugs are recommended to treat the symptoms of 
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diabetic neuropathy. These include metoclopramide for gastroparesis and 
amitriptyline, imiprimine, paroxetine and citalopram which have been recommended 
to relieve pain (Fowler, 2008). 
2.6 Knowledge of diabetes among health care professionals 
The studies on health care providers’ knowledge on diabetes is more difficult to 
obtain since there are only a few studies on the topic throughout the world.  Most 
studies evaluate patient knowledge on diabetes rather than the knowledge of health 
care providers.  Moreover, the studies on health care knowledge are usually more 
specific, such as on diabetic nutrition or exercise (Tay et al., 2007)  
2.6.1  General knowledge on diabetes among health care professionals 
Previous studies on the level of health care providers’ knowledge on diabetes have 
shown a great variation in their results.  Most studies have found that health care 
providers have low knowledge on diabetes care (O’Brien, 2003; Chen et al., 2004; 
Tay et al., 2007; Derr et al., 2007; Torres et al., 2010). In addition, most reports do 
not address the effect of knowledge on patient outcome, which is one of the 
objectives of the current study. El-Deirawi and Zuraikat (2001) conducted a non-
experimental descriptive design among registered nurses in Western Pennsylvania.  
The study aimed to assess the registered nurses’ actual and perceived knowledge on 
diabetes in a community hospital and care home.  The study used the Diabetes  Basic 
Knowledge Test ( DBKT) questionnaire and Diabetes Self Report Tool (DSRT) 
developed and validated by Drass et al. (1989 ). This questionnaire was specifically 
developed to study nurses’ knowledge on diabetes.  The DBKT consisted of 45 
questions, while the DSRT contained 22 statements. The questionnaire was sent to 
169 nurses working in a hospital and 60 nurses in a nursing home. The number of 
